Posted on 10 月 15, 202110/15/21
EPP Studio Live Webinar — Impact of COVID-19 Pandemic on German Healthcare System
Posted on 10 月 6, 202110/6/21
EPP Studio Live Webinar — EU Joint Procurement of COVID-19 Vaccines: A Model for Future Market Access in Europe?
Posted on 10 月 5, 202110/5/21
WEBINAR: The New Path to European Pharmaceutical Commercialisation
Posted on 9 月 30, 20219/30/21
EPP Studio Live Webinar — Looking Ahead: Landscape of the Key Price and Market Access Trends in Europe
Posted on 9 月 14, 20219/14/21
Simplifying EU Distribution to Maximize Cost Efficiency and Speed to Market for Patients and Manufacturers
Posted on 6 月 23, 20216/23/21
INFOGRAPHIC: What You Need To Know About The Tender Landscape In Europe
Posted on 5 月 12, 20215/12/21
The Secret’s Out: The Impact of Net Price Transparency
Posted on 3 月 17, 20213/17/21
Change Is Happening in the EU: What Pharma Companies Need to Know About the European Union’s New Pharmaceutical Strategy
Posted on 12 月 4, 202012/4/20
A New Pharmaceutical Strategy for Europe
Posted on 11 月 5, 202011/5/20